FDA | What's New

Drug Trials Snapshot: FABHLATA

Follow
FABHALTA is a prescription drug that is a complement factor B inhibitor, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).
favicon
fda.gov
fda.gov
Create attached notes ...